Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Tubeless Omnipod will communicate directly with Tidepool Loop app. Insulet’s own Horizon hybrid closed loop expected to launch in second-half of 2020
Amarin’s Vascepa, an omega-3 fatty acid, is shown to lower risk of heart attack, stroke, and heart-related death for adults with high risk for heart disease with...
A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!
Eli Lilly to donate 200,000 insulin pens and provide $2 million for diabetes education to 200 free clinics across the United States by 2022
Control-IQ Hybrid Closed Loop on track to launch in the US by the end of 2019 for those ages 14 and older; first system with automatic correction boluses and no...
A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease
Jamie Kurtzig, a high school student living with type 1 diabetes, just published a book of 100 poems that she has written over the last ten years
The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
Data from the CDC show that 17% of people in Colorado self-report an inactive lifestyle, up to 48% of people in Puerto Rico
diaTribe Community Manager, Cherise Shockley, shares the story of her diabetes diagnosis and how that diagnosis affected her family
This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years)
The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...
FDA approval the fast-acting insulin for children means that children will have more flexibility in their mealtime insulin dosing
A few weeks ago, Kelly experienced severe hypoglycemia (she left her RileyLink in her basement by accident!) – lucky for her, she had just picked up a new emergency...
Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo
Approved in the US in 2018, the system stops insulin delivery when low blood sugar is predicted
The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no...
JDRF and Beyond Type 1 are teaming up to support the type 1 community through education, programs, and advocacy
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...

Pages